CX3CL1 and Alzheimer disease: Conversely, other reports demonstrated increased levels of CX3CL1 protein in the hippocampi of early (Braak-Tau stages II-IV) (Lastres-Becker et al. 2014) and late stage of AD (Braak-Tau stages V-VI) (Dworzak et al. 2015) as compared to healthy controls.